CNN: Expert witness: Johnson & Johnson's role in opioid crisis may be 'worse' than Purdue's
One of the nation's top experts on opioid addiction said Tuesday that Johnson & Johnson's role in the current epidemic may be even "worse" than that of Purdue Pharma, the maker of OxyContin.
Dr. Andrew Kolodny, the co-director of the Opioid Policy Research Collaborative at Brandeis University, made the comments during the 11th day of the historic trial in Oklahoma that is aimed at holding Johnson & Johnson and its subsidiaries responsible for the state's opioid epidemic.
"Until I had an opportunity to review discovery documents," Kolodny testified, "I really was not aware of how bad Johnson & Johnson was."
Replies